Consolidated Condensed Statements of Operations (USD $) In Millions, except Per Share data, unless otherwise specified	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2013
Revenue	$ 4,683.1	$ 5,602.0
Cost of sales	1,222.7	1,158.3
Research and development	1,109.3	1,348.1
Marketing, selling, and administrative	1,484.9	1,652.0
Asset impairment, restructuring, and other special charges	31.4	21.7
Other - net, (income) expense	(56.0)	(529.2)
Cost of sales, operating expenses, and other-net	3,792.3	3,650.9
Income before income taxes	890.8	1,951.1
Income taxes	162.9	403.1
Net income	$ 727.9	$ 1,548.0
Weighted-average number of common shares outstanding, including incremental shares	1,072.7	1,087.9
Basic earnings per share	$ 0.68	$ 1.42
Weighted-average number of common shares outstanding, including incremental shares and stock options	1,075.8	1,091.9
Diluted earnings per share	$ 0.68	$ 1.42
Dividends paid per share	$ 0.49	$ 0.49